State of Wyoming’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-4,626
Closed -$77.7K – 1957
2026
Q1
$77.7K Buy
4,626
+3,368
+268% +$60.3K 0.01% 1363
2025
Q4
$20.2K Buy
1,258
+28
+2% +$417 ﹤0.01% 1692
2025
Q3
$15.2K Buy
1,230
+87
+8% +$1.02K ﹤0.01% 1733
2025
Q2
$13.2K Sell
1,143
-1,692
-60% -$20.1K ﹤0.01% 1747
2025
Q1
$42.5K Buy
2,835
+571
+25% +$9.56K 0.01% 1512
2024
Q4
$39.2K Sell
2,264
-320
-12% -$6.17K 0.01% 1476
2024
Q3
$47.9K Buy
2,584
+700
+37% +$14.1K 0.01% 1471
2024
Q2
$38.2K Buy
1,884
+693
+58% +$12.3K 0.01% 1430
2024
Q1
$20.3K Buy
1,191
+151
+15% +$2.38K ﹤0.01% 1537
2023
Q4
$18.4K Buy
1,040
+459
+79% +$9.25K ﹤0.01% 1547
2023
Q3
$13.9K Sell
581
-866
-60% -$21.3K ﹤0.01% 1522
2023
Q2
$33.6K Buy
1,447
+436
+43% +$9.86K 0.01% 1261
2023
Q1
$22.3K Buy
+1,011
New +$23.7K 0.01% 1400

Other funds holding CLB

State of Wyoming's CLB Position: Q2 2026 in Review

State of Wyoming sold out of Core Laboratories (CLB) in Q2 2026, closing a stake of 4,626 shares — an estimated $77.7K sold.

State of Wyoming first reported a position in CLB in Q1 2023 and held it in 13 quarters. The position peaked at $77.7K in Q1 2026. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • State of Wyoming reported no remaining Core Laboratories position as of Q2 2026 after selling out during the quarter.
  • State of Wyoming sold 4,626 Core Laboratories shares in Q2 2026, an estimated $77.7K.
  • State of Wyoming first reported a position in Core Laboratories in Q1 2023 and held it in 13 quarters.
  • State of Wyoming's Core Laboratories position peaked at $77.7K in Q1 2026.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.